mrna has strong management ability

lindsay877
2021-08-06

My favorite points from the EC: 1. Buy back plan of shares. This strengthens our current SP, and it is placing another layer of defence against future short activity. 2. Bancel saying that he is not interested to expand Moderna's pipeline to include small molecules. He said Moderna loves information molecules too much that they would just want to focus on it. They are not yet planning to play it safe. No diversification to non-mrna modality, they are going all out on this one. GL.$Moderna, Inc.(MRNA)$

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法